C16 Dihydroceramide (d18:0/16:0)
CAS: 5966-29-0
Rif. 3D-FAA96629
| 5mg | Fuori produzione | ||
| 10mg | Fuori produzione | ||
| 25mg | Fuori produzione | ||
| 50mg | Fuori produzione | ||
| 100mg | Fuori produzione |
Informazioni sul prodotto
Nome:
C16 Dihydroceramide (d18:0/16:0)
Sinonimi:
- Hexadecanamide, N-[(1S,2R)-2-hydroxy-1-(hydroxymethyl)heptadecyl]-
- Hexadecanamide, N-[2-hydroxy-1-(hydroxymethyl)heptadecyl]-, [R-(R*,S*)]-
- N-Palmitoyl-D(+)-erythro-sphinganine
- N-[(1S,2R)-2-Hydroxy-1-(hydroxymethyl)heptadecyl]hexadecanamide
- Hexadecanamide, N-[2-hydroxy-1-(hydroxymethyl)heptadecyl]-, D-erythro-
Descrizione:
Dihydroceramide is a lipid that is synthesized from sphingosine, an amino acid. The hydration of the molecule to form dihydroceramide may be a potential biomarker for cells and tissues undergoing dehydration. Dihydroceramide has been shown to have antimicrobial activity against bacterial and fungal strains, such as endophytic fungus. It also has been shown to inhibit cancer cell growth in vitro, as well as cellular lipid biosynthesis. This lipid may also have a role in the regulation of at1 receptor activity by binding to this receptor and inhibiting its activation.
Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Biosynth
Conservazione lunga:
Note:
Proprietà chimiche
Peso molecolare:
539.92 g/mol
Formula:
C34H69NO3
Purezza:
Min. 95%
MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:
